+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygosity for hemoglobin and Korle-Bu: Moderate microcytic hemolytic anemia and acceleration of crystal formation

Compound heterozygosity for hemoglobin and Korle-Bu: Moderate microcytic hemolytic anemia and acceleration of crystal formation

Blood 82(6): 1907-1912

We report here that compound heterozygosity for hemoglobin Korle-Bu (HbKB) and HbC (beta-6 Glu fwdarw Lys) is associated with moderate chronic hemolytic anemia with microcytosis. To understand the pathogenesis of this syndrome, we have studied the effect of Hb Korle-Bu (KB = beta-73 Asp fwdarw Asn) on the crystallization of HbC. We have previously established that fetal Hb (HbF) inhibits the crystallization of HbC. In contrast, HbS accelerates crystallization affecting the pathogenesis of SC disease. We now report on in vitro crystallization of mixtures of HbKB, HbC, and various amounts of HbF and the native hemolysate of a child who is a compound heterozygote for HbKB and HbC. At 6 months of age, the propositus' hemolysate contained 55% HbKB, 39% HbC, and 6% HbF. Crystals formed within 2 minutes compared with 30 minutes for the mixture of 40% HbC:60% HbS and with 180 minutes for 40% HbC:60% HbA. The morphology of the crystals formed was cubic, in contrast with the tetragonal crystals observed in CC and SC disease. Early crystals did not exhibit "sharp edges" until 45 minutes. Purified HbKB formed aggregates but not crystals after 24 hours. Isopycnic gradients showed that the KB/C compound heterozygotes have red blood cell (RBC) densities intermediate between the AC and CC phenotype and similar to SC disease. The surface residue beta-73, known to participate in areas of interaction of the deoxy HbS polymer, can now be assigned to areas of contact in HbC containing crystals. The hemolysis observed in the HbKB/C compound heterozygote is likely to be secondary to the acceleration of Hb crystallization. The microcytosis and increased RBC density is clearly the consequence of the presence of HbC, but the basis of the increased RBC pathology compared with AC trait, despite the low proportion of HbC (35% to 40%), remains to be elucidated.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 008369361

Download citation: RISBibTeXText

PMID: 7691242

Related references

Compound heterozygosity for hemoglobin S [beta6(A3)Glu6Val] and hemoglobin Korle-Bu [beta73(E17)Asp73Asn. Laboratory Hematology 15(3): 20-24, 2009

Compound heterozygosity for hemoglobin C and hemoglobin Korle-Bu. Laboratory Hematology 14(3): 30-34, 2008

Mild Microcytic Anemia in an Infant with a Compound Heterozygosity for Hb C (HBB: c.19G > A) and Hb Osu Christiansborg (HBB: c.157G > A). Hemoglobin 40(3): 208-209, 2017

Hemolytic anemia apparently caused by heterozygosity for hemoglobin J-Baltimore. Journal of the Medical Association of Georgia 71(8): 547-549, 1982

Compound Heterozygosity for Hb Alperton (HBB: c.407C>T) and IVS-I-5 (G>C) (HBB: c.92+5G>C) Mutations Presenting as a Moderate Anemia in an Indian Family. Hemoglobin 42(2): 141-142, 2018

Unstable hemoglobin Rush [beta 101(G3) Glu>Gln, HBB:c.304G>C] in a Brazilian family with moderate hemolytic anemia. Annals of Hematology 91(7): 1091-1096, 2012

Hemoglobin E: another cause of microcytic anemia in North America. Southern Medical Journal 79(12): 1524-1526, 1986

Hypochromic microcytic anemia with a variant hemoglobin. American Journal of Hematology 84(1): 59, 2008

Case of hemoglobin H constitutional microcytic anemia. Il Policlinico. Sezione Pratica 64(36): 1301-1304, 1957

Compound heterozygosity for Hb Korle-Bu (beta(73); Asp-Asn) and Hb E (beta(26); Glu-Lys) with a 3.7-kb deletional alpha-thalassemia in Thai patients. Annals of Hematology 81(7): 389-393, 2002

Compound heterozygosity for two alpha-globin gene defects, Hb Taybe (alpha 1; 38 or 39 minus Thr) and a poly A mutation (alpha 2; AATAAA-->AATAAG), results in a severe hemolytic anemia. American Journal of Hematology 47(3): 198-202, 1994

Prolidase deficiency associated with hemoglobin O trait and microcytic anemia. International Journal of Dermatology 45(7): 867-868, 2006

Diagnosis of a novel hemoglobinopathy of compound heterozygosity of hemoglobin S/hemoglobin Q India. Clinica Chimica Acta; International Journal of Clinical Chemistry 442: 33-35, 2015

Moderate and severe microcytic anemia in the emergency department: indicators of care. Clinical Pediatrics 48(9): 902-903, 2010

Familial hemolytic anemia with Heinz body formation after splenectomy and mesobilifuscin in urine with abnormal hemoglobin. Deutsche Medizinische Wochenschrift 92(3): 98-104, 1967